Sofia, Bulgaria

Sascha R Mihaylova

This inventor holds 1 USPTO granted patent. Top assignee: Tpo 'Pharmachim'. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sascha R Mihaylova. Retrieved from https://idiyas.com/inventor/sascha-r-mihaylova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sascha R Mihaylova

Introduction

Sascha R Mihaylova is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-ulcer compositions. His innovative work aims to improve the treatment and prophylaxis of stomach and duodenum ulcers, including stress ulcers.

Latest Patents

Sascha R Mihaylova holds 1 patent for an anti-ulcer composition. This invention relates to an improved formulation that provides potent anti-ulcer activity while dramatically reducing toxicity and harmful side effects. The composition includes a histamine H₂ antagonist based on a guanidine derivative and at least one 4-phenyl-tetrahydroisoquinoline antidepressant. The specific ratios of the components are carefully designed to enhance efficacy and safety.

Career Highlights

Mihaylova is associated with Tpo Pharmachim, where he continues to work on innovative pharmaceutical solutions. His research focuses on creating effective treatments that minimize adverse effects, showcasing his commitment to improving patient care.

Collaborations

Sascha collaborates with talented coworkers, including Snejana G Vitkova and Margarita D Dryanska. Their combined expertise contributes to the advancement of pharmaceutical innovations.

Conclusion

Sascha R Mihaylova's work in developing anti-ulcer compositions highlights his dedication to innovation in the pharmaceutical industry. His contributions are paving the way for safer and more effective treatments for patients suffering from ulcers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…